Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation-Reference-Cited by-同舟云学术

Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation

Published:2003 Issue:1 Volume:42 Page:8-23
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Saarinen-Pihkala Ulla M.,Gustafsson G.,Carlsen N.,Flaegstad T.,Forestier E.,Glomstein A.,Kristinsson J.,Lanning M.,Schroeder H.,Mellander L.,

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference49 articles.

1. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

2. A Population-Based Study of Childhood Acute Lymphoblastic Leukemia Diagnosed from July 1981 through June 1985 in the Five Nordic Countries.

3. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early post‐induction augmented therapy improves outcome in children and adolescents with T ‐cell acute lymphoblastic leukemia;Cancer Reports;2022-08-12

2. Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia;Scientific Reports;2022-06-23

3. Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies;Frontiers in Oncology;2021-10-27

4. Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post‐remission treatment for children with very high‐risk philadelphia chromosome negative B‐cell acute lymphoblastic leukaemia in first complete remission;British Journal of Haematology;2019-11-14

5. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia;Pediatric Blood & Cancer;2019-11